Fluorine-18 FDG-PET in detecting local recurrence and distant metastases in breast cancer - Taiwanese experiences
Journal
Cancer Investigation
Journal Volume
20
Journal Issue
5-6
Pages
725-729
Date Issued
2002
Author(s)
Abstract
Fluorine-18 fluorodeonyglucose positron emission tomography (FDG-PET) was used to detect local recurrence, axillary lymph node (LN) involvement and distant metastases in patients with breast cancer. Thirty-six female patients with breast cancer s/p operation underwent FDG-PET studies. Findings were confirmed by histology following surgery and/or biopsy or negative follow-up results over a period of at least one year. In the evaluation of local recurrence, the diagnostic sensitivity, specificity, and accuracy of FDG-PET was 100, 96.8, and 97.2%, respectively. In the evaluation of axillary LN involvement, sensitivity, specificity, and accuracy was 80, 100, and 97.2%, respectively. In the evaluation of distant metastases, the diagnostic sensitivity, specificity, and accuracy was 83.3, 85.2, and 84.4%, respectively. The FDG-PET is a useful diagnostic tool in detecting local recurrence, axillary LN involvement, and distant metastasis.
SDGs
Other Subjects
fluorodeoxyglucose f 18; diagnostic agent; radiopharmaceutical agent; adult; aged; article; axillary lymph node; breast biopsy; breast cancer; clinical article; computer assisted tomography; diagnostic accuracy; diagnostic imaging; female; follow up; human; human tissue; lymph node biopsy; lymph node metastasis; metastasis; nuclear magnetic resonance imaging; positron emission tomography; priority journal; sensitivity and specificity; breast tumor; computer assisted emission tomography; lymph node metastasis; middle aged; pathology; reproducibility; scintiscanning; tumor recurrence; Adult; Aged; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed
Type
journal article